Q1 2026 saw significant activity in the digital health sector, with mergers and acquisitions filling the gap left by a stagnant IPO market. Hims & Hers made headlines by acquiring the Australian company Eucalyptus for $240 million upfront, potentially rising to $1.15 billion based on performance. This move provides Hims & Hers a strategic entry into the Australian market. Similarly, Sword Health paid $285 million for Kaia Health, a German digital musculoskeletal company, which enhances Sword’s presence in Europe and taps into a large insured population through Germany’s reimbursement system for digital health applications. Universal Health Services acquired Talkspace for $835 million, marking a notable exit for a public company in a challenging market. The deal highlights how Talkspace’s valuation dropped significantly since its SPAC debut, reflecting a broader trend in the digital health market as it adjusts post-pandemic. On the funding side, OpenEvidence raised $250 million at a $12 billion valuation, while WHOOP secured $575 million, pushing its valuation above $10 billion. Other companies, including Devoted Health and Talkiatry, also raised substantial amounts, signifying strong investor interest despite the IPO freeze. Seven companies achieved unicorn status this quarter, indicating a robust pipeline of new ventures. Eight Sleep raised $50 million to reach a $1.5 billion valuation, and eMed surpassed $2 billion with notable leadership backing. The concentration of capital among a few high-performing companies suggests that while the market is selective, it remains vibrant. Strategic M&A activity is on the rise, focusing on geographic expansion and integration of digital capabilities into established care models.